Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Prostate cancer Q&A: Improving detection and reducing overtreatment

2.

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

3.

A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.

4.

Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL

5.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot